Drug-induced hyperkalaemia is frequent.
Especially with ACE inhibitors, spironolactone, potassium salts, heparin and sartans.
D047228:Angiotensin II Type 1 Receptor Blockers / Q000009:adverse effects*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects*; D005602:France; D006493:Heparin / Q000009:adverse effects*; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced*; D017680:Potassium Compounds / Q000009:adverse effects*; D013148:Spironolactone / Q000009:adverse effects*
D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D017680:Potassium Compounds; D013148:Spironolactone; D006493:Heparin